Techcyte Expands its Board and Adds World-Class Advisers to its Team
Techcyte recently expanded its board and advisory team through the addition of world-class medical, corporate strategy, and laboratory diagnostics experts.
Ben Cahoon, the new CEO of Techcyte, said, “To pursue our go-to-market strategy, we can’t do it alone. Our advisers have been invaluable in focusing our efforts on the highest value markets and tests.”
Techcyte Board
- Dr. Mohamed Salama, Hematopathologist & Chief Medical Officer, Mayo Clinic Laboratories
- Kent Gordon, Chief Financial Officer, ARUP Reference Laboratories
- Michael Aicher - President, Alveo Technologies
- Kyle Wilson - Partner, BroadOak Capital Partners
- Ralph Yarro - Founder, Chairman of the Board, Techcyte
- Michael Wolfgramm - Partner, Atua Ventures
- Ben Cahoon - CEO, Techcyte
- Rick Smith - President, Techcyte
Advisers
- Dr. David Gardiner - Veterinary Pathologist
- Dr. John Haines - Retired Mycologist for New York State
- Dr. Angelica Rodriguez Baca - Cytopathologist
- Dr. Stéphane Gidenne - CEO, Ketterthill Laboratory, Luxembourg
- Richard Johnson - CEO of Air Allergen and Mold Testing
As Techcyte expands its platform to provide additional solutions, we’ll continue to look for additional world-class experts to guide and direct our efforts. If you’re interested in using or integrating with the Techcyte deep learning image analysis platform to create new algorithms or markets, please contact Ben Cahoon. ben.cahoon@techcyte.com.
###
About Techcyte
Headquartered in Lindon, Utah, Techcyte, Inc. was founded in 2013 and is the world leader in AI-based cellular digital diagnostics. Techcyte's use of deep machine learning to perform automated analysis of whole slide microscopy images is revolutionizing digital diagnostics in research, biopharma, environmental monitoring, and human and animal health. Visit www.techcyte.com for more information.
Techcyte Media Contact:
Matt Yarro, 801-980-0414, matt.yarro@techcyte.com
Matt Yarro
Techcyte, Inc.
+1 801-980-0414
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.